Actively Recruiting

Age: 50Years +
All Genders
Healthy Volunteers
NCT07284264

Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study

Led by Xuanwu Hospital, Beijing · Updated on 2025-12-16

6000

Participants Needed

6

Research Sites

19 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The investigators propose a stepwise screening approach. The first step involves rapid digital pre-screening of cognitive function through three components: the SCD-9 questionnaire to capture subjective cognitive complaints, a digital cognitive assessment to evaluate objective performance, and a predictive model to estimate future dementia risk in cognitively normal individuals. The second step confirms the presence of AD pathology using blood-based biomarkers, with a head-to-head comparison of multiple novel candidates to identify those with the greatest diagnostic utility.

CONDITIONS

Official Title

Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study

Who Can Participate

Age: 50Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 50 and above
  • Living in the community for at least one year with established medical records
  • No history of cognitive disorders such as mild cognitive impairment, dementia, or Alzheimer's disease
  • Not currently using anti-dementia medications like cholinesterase inhibitors or memantine
  • Willing to participate in the study
  • The participant or their relatives can communicate normally in Chinese
  • High-risk for dementia including complaints of cognitive decline, family history of AD in first-degree relatives, or known ApoE e4 carrier
Not Eligible

You will not qualify if you...

  • Presence of severe mental disorders such as bipolar disorder or schizophrenia
  • Having any disease that makes it impossible to complete cognitive assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Xuanwu Hospital, Capital Medical University

Beijing, China

Actively Recruiting

2

Hainan Medical University

Hainan, China

Actively Recruiting

3

General Hospital of Ningxia Medical University

Ningxiang, China

Actively Recruiting

4

The First Hospital of China Medical Unversity

Shenyang, China

Actively Recruiting

5

Shenzhen Center For Chronic Disease Control

Shenzhen, China

Actively Recruiting

6

Yichun People'S Hospital

Yichun, China

Actively Recruiting

Loading map...

Research Team

Y

Yi Tang, M.D., Ph.D

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here